Clinical Trial Update: ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a four-drug regimen (sofosbuvir, simeprevir, daclatasvir, ribavirin) in Egyptian participants with chronic hepatitis C virus infectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Simeprevir/Daclatasvir/Ribavirin

Snippet

Sponsor: Beni-Suef University | Conditions: Chronic Hepatitis C Virus Infection | Phase 1, Phase 2 | Status: COMPLETED